Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain, suspected Acute Coronary Syndrome(ACS) and Heart Failure(HF), etc.
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.
BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
Lp-PLA2 Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the lipoprotein-associated phospholipase A2 (Lp-PLA2) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
IL-6 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Interleukin-6 (IL-6) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Ferritin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of malignant tumor or inflammation.
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.
IPv6 network supported 
